These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16792445)

  • 21. The use of a clinical decision support tool to assess the risk of QT drug-drug interactions in community pharmacies.
    Berger FA; van der Sijs H; van Gelder T; van den Bemt PMLA
    Ther Adv Drug Saf; 2021; 12():2042098621996098. PubMed ID: 33708374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug shortages may compromise patient safety: Results of a survey of the reference pharmacies of the Drug Commission of German Pharmacists.
    Said A; Goebel R; Ganso M; Zagermann-Muncke P; Schulz M
    Health Policy; 2018 Dec; 122(12):1302-1309. PubMed ID: 30337159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.
    Somogyi-Végh A; Ludányi Z; Erdős Á; Botz L
    BMC Pharmacol Toxicol; 2019 May; 20(1):36. PubMed ID: 31151485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The feasibility of QR-code prescription in Taiwan.
    Lin CH; Tsai FY; Tsai WL; Wen HW; Hu ML
    J Clin Pharm Ther; 2012 Dec; 37(6):643-6. PubMed ID: 22612397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector-a national study.
    Deibl S; Mueller D; Kirchdorfer K; Stemer G; Hoppel M; Weidmann AE
    Int J Clin Pharm; 2020 Aug; 42(4):1050-1060. PubMed ID: 32494989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of computerized clinical decision support in community pharmacy.
    Curtain C; Peterson GM
    J Clin Pharm Ther; 2014 Aug; 39(4):343-8. PubMed ID: 24806361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug safety alert generation and overriding in a large Dutch university medical centre.
    van der Sijs H; Mulder A; van Gelder T; Aarts J; Berg M; Vulto A
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):941-7. PubMed ID: 19579216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients' perceived value of pharmacy quality measures: a mixed-methods study.
    Shiyanbola OO; Mort JR
    BMJ Open; 2015 Jan; 5(1):e006086. PubMed ID: 25600253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions.
    Buurma H; De Smet PA; Egberts AC
    Drug Saf; 2006; 29(8):723-32. PubMed ID: 16872246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants: an intervention study in community pharmacies.
    Capiau A; Mehuys E; Grymonprez M; Van Tongelen I; Christiaens T; Tommelein E; Philippe G; Lahousse L; De Backer T; Boussery K
    Thromb Res; 2024 Jun; 238():223-231. PubMed ID: 38733695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in high-priority drug-drug interaction alerts across institutions and electronic health records.
    McEvoy DS; Sittig DF; Hickman TT; Aaron S; Ai A; Amato M; Bauer DW; Fraser GM; Harper J; Kennemer A; Krall MA; Lehmann CU; Malhotra S; Murphy DR; O'Kelley B; Samal L; Schreiber R; Singh H; Thomas EJ; Vartian CV; Westmorland J; McCoy AB; Wright A
    J Am Med Inform Assoc; 2017 Mar; 24(2):331-338. PubMed ID: 27570216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Warnings for drug-drug interactions in consumer medication information provided by community pharmacies.
    Panich J; Gooden A; Shirazi FM; Malone DC
    J Am Pharm Assoc (2003); 2019; 59(1):35-42. PubMed ID: 30416068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug-drug interaction alerts.
    Baysari MT; Zheng WY; Li L; Westbrook J; Day RO; Hilmer S; Van Dort BA; Hargreaves A; Kennedy P; Monaghan C; Doherty P; Draheim M; Nair L; Samson R
    BMJ Open; 2019 Aug; 9(8):e026034. PubMed ID: 31427312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clarity and applicability of drug-drug interaction management guidelines: a systematic appraisal by general practitioners and community pharmacists in the Netherlands.
    Floor-Schreudering A; De Smet PA; Buurma H; Amini S; Bouvy ML
    Drug Saf; 2011 Aug; 34(8):683-90. PubMed ID: 21751828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ASHP national survey of hospital-based pharmaceutical services--1994.
    Santell JP
    Am J Health Syst Pharm; 1995 Jun; 52(11):1179-98. PubMed ID: 7656108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-drug interaction checking assisted by clinical decision support: a return on investment analysis.
    Helmons PJ; Suijkerbuijk BO; Nannan Panday PV; Kosterink JG
    J Am Med Inform Assoc; 2015 Jul; 22(4):764-72. PubMed ID: 25670751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the safety features of electronic patient medication record systems used in community pharmacies in England.
    Ojeleye O; Avery AJ; Boyd MJ
    Br J Clin Pharmacol; 2014 Aug; 78(2):401-9. PubMed ID: 24528252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions.
    Khandelwal N; Duncan I; Rubinstein E; Ahmed T; Pegus C
    J Manag Care Pharm; 2012 Apr; 18(3):247-55. PubMed ID: 22468733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.
    Malone DC; Abarca J; Hansten PD; Grizzle AJ; Armstrong EP; Van Bergen RC; Duncan-Edgar BS; Solomon SL; Lipton RB
    J Am Pharm Assoc (2003); 2004; 44(2):142-51. PubMed ID: 15098848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of high-risk drug-drug interactions in paediatric inpatients: a retrospective, single-centre cohort analysis.
    Dieu LW; Leuppi-Taegtmeyer AB; van den Anker J; Trachsel D; Gotta V
    Swiss Med Wkly; 2019 Aug; 149():w20103. PubMed ID: 31422575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.